| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.16 | 2e-06 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.21 | 9e-06 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0002 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0006 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0006 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0009 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |